Pharmacotherapy for chronic depression

Psychiatric Clinics of North America

Volumn 19, Issue 1, 1996, Pages 121-132

  Friedman, R A ^a   Kocsis, J H ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMISULPRIDE; AMITRIPTYLINE; DESIPRAMINE; FLUOXETINE; FLUPENTIXOL; IMIPRAMINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PHENELZINE; RITANSERIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CHRONIC DISEASE; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; DYSTHYMIA; GASTROINTESTINAL SYMPTOM; HUMAN; INSOMNIA; NERVOUSNESS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SEDATION; SIDE EFFECT; SOCIAL DISABILITY; SWEATING; TREMOR;

EID: 0029869151     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(05)70277-X     Document Type: Article

References (31)

1. H.S. Akiskal T.L. Rosenthal R.F. Haykal Characterological depressions: Clinical and sleep EEG findings separating “subaffective dysthymias from character spectrum disorders Arch Gen Psychiatry 37 1980 777 783
2. Antidotes for antidepressant-induced sexual dysfunction A.J. Gelenber Biological Therapies in Psychiatry Newsletter 15 1992 33 35
3. D. Bakish Y.D. Laperierre R. Weinstein Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder J Clin Psychopharmacology 13 1993 409 414
4. G. Bersani S. Pozzi F Marini 5-HT2 receptor antagonism in dysthymic disorder: A double-blind placebo controlled study with ritanserin Acta Psychiatr Scand 83 1991 244 248
5. R. Feder Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients J Clin Psychopharmacol 52 1991 32 33
6. R.A. Friedman Social and occupational adjustment in chronic depression J.H. Kocsis D. Klein Chronic Depression and Their Treatment 1995 Guilford Press 82 102
7. R.A. Friedman J. Mitchell J.H. Kocsis Retreatment of relapse following desipramine discontinuation in dysthymia Am J Psychiatry 152 1995 926 928
8. R.A. Friedman J.C. Markowitz M. Parides J.H. Kocsis Acute response of social functioning in dysthymic patients with desipramine J Affect Disord 34 1995 85 88
9. R.A. Friedman M. Parides R. Baff J.H. Kocsis Predictors of response to desipramine in dysthymia J Clin Psychopharmacol 15 1995 280 283
10. A. Geisler O. Mygind R. Knudsen M. Sloth-Nielson Ritanserin and flupenthixol in dysthymic disorder. A controlled double-blind study in general practice Nord J Psychiatry 46 1992 237 243
11. J.D. Guelfi J.F. Pichot P Dreyfus Efficacy of tianeptine in anxious depressed patients Neuropsychobiology 22 1989 41 48
12. W. Harrison J. Rabkin J.W. Stewart Phenelzine for chronic depression: A study of continuation treatment J Clin Psychiatry 47 1986 346 349
13. D. Hellerstein P. Yanowitch J. Rosenthal A randomized double-blind study of fluoxetine versus placebo in treatment of dysthymia Am J Psychiatry 150 1993 1169 1175
14. J.B. Herman A.W. Brotman M.H. Pollack Fluoxetine induced sexual dysfunction J Clin Psychiatry 51 1990 25 27
15. Keller MB: Treatment of chronic depression with sertraline or imipramine: Preliminary blinded response rates. Psychopharmacology Bulletin, in press
16. M.B. Keller R.W. Shapiro “Double depression”: Superimposition of acute depressive episodes on chronic depressive disorders Am J Psychiatry 139 1982 438 442
17. M.B. Keller P.W. Lavori J. Rice The persistent risk ofchronicity in recurrent episodes of nonbipolar major depressive disorder: A prospective follow-up Am J Psychiatry 143 1986 24 28
18. J.H. Kocsis A.J. Frances C.V. Voss Imipramine treatment for chronic depression Arch Gen Psychiatry 45 1988 253 257
19. Kocsis JH, Friedman RF, Markowitz JC, et al: Maintenance therapy for chronic depression: A controlled clinical trial of desipramine. (in press)
20. J.H. Kocsis R.A. Friedman J.C. Markowitz Stability of remission during TCA continuation therapy for dysthymia Psychopharmacol Bull 31 1995 213 216
21. J.H. Kocsis M.E. Thase L. Koran Pharmacotherapy for pure dysthymia: Sertraline vs imipramine and placebo Eur Neuropsychopharmacol 4 1994 204
22. Y. Lecrubier The treatment of dysthymics with a dopaminergic presynaptic blocker Neuropsychopharmacology 10 suppl 3 1994 302
23. D.B. Marin J.H. Kocsis A.J. Frances M. Parides Desipramine for the treatment of “pure” dysthymia versus “double” depression Am J Psychiatry 151 1994 1079 1080
24. Ravindran AV, Chydzik J, Bialik RJ, et al: Serotonin in primary dysthymia. Presented at the Annual Meeting of the American Psychiatric Association, San Francisco, May 1993
25. D.A. Regier W.E. Narrow D.S. Rae The defacto US mental and addictive disorders service system: Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services Arch Gen Psychiatry 50 1993 85 94
26. A. Reyntjens Y.G. Gelders M.J. Hoppenbrouwers G.V. Bussche Thymosthenic effects of ritanserin (R 55667), a centrally acting serotonin-S2 receptor blocker Drug Development and Research 8 1986 205 211
27. J.W. Stewart P.J. McGrath M.R. Liebowitz Treatment outcome validation of DSM-III depressive subtypes: Clinical usefulness in outpatients with mild to moderate depression Arch Gen Psychiatry 42 1985 1148 1153
28. J.W. Stewart P.J. McGrath F.M. Quitkin Relevance of DSM-III depressive subtype and chronicity of antidepressant efficacy in atypical depression Arch Gen Psychiatry 46 1989 1080 1087
29. J. Vallejo C. Gasto R. Catalan Double-blind study of imipramine versus phenelzine in melancholic and dysthymic disorders Br J Psychiatry 151 1987 639 651
30. M. Versiani Pharmacotherpay of dysthymia: A controlled study with imipramine, moclobemide, or placebo Neuropsychopharmacology 10 suppl 3 1994 298
31. M.M. Weissman P.J. Leaf M.L. Bruce L. Florio The epidemiology of dythymia in five communities: Rates, risks, comorbidity, and treatment Am J Psychiatry 145 1988 815 819